alexa Xi Lin | Texas A&M Health Sciences Center
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Xi Lin

Xi Lin Xi Lin
Post-Doctorate
Texas A&M Health Sciences Center
USA
 
Biography

-

Research Interest

Hydrocephalus in humans is a severe neurological disorder characterized by an excessive accumulation of CSF in the brain. It affects about 1 in every 500 children based on an estimation by the National Institute of Neurological Disorders and Stroke in the USA. The precise causes of hydrocephalus remain largely unknown. Accumulating evidence suggests that genetic factors are critical for the pathogenesis of hydrocephalus. Congenital hydrocephalus, caused by genetic abnormalities, is the most common type of hydrocephalus. There were at least nine genes identified to be closely associated with congenital hydrocephalus pathogenesis in animal studies, but few of them were verified in humans. My research is continual identification of new genes/loci linked to this medical disorder and expand our knowledge of the genetic components of the disease. Gliomas, tumors from glial origin, are the most prevalent primary tumors in the brain. Glioblastoma multiforme (GBM, World Health Organization grade IV), the highest grade of gliomas, are the most common malignant primary brain tumors with rapid and invasive growth, and fast development of resistance to chemoradiotherapy. Despite significant advances in neurosurgery and multiple therapeutic strategies, the median overall survival of glioblastoma patients remains just over 1 year. There is a critical need for new molecular targets, concepts, and approaches to treat this devastating disease. We found, in our study, that RND3 (also called RhoE), a small GTPase, as an endogenous inhibitor of Notch and snail signaling, downregulated in human GBM and responsible for the hyperactivation of Notch and snail signaling, which promotes gliomagenesis and invasion respectively. My research interests is to continually explore pathological role of RND3 in human GBM progression and invasion as well as the associated animal studies.

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords